Intentional Wellness MD Review: Following the Care From Intake to Home Delivery

A prescription delivered to your door is the last visible step in a process involving several different responsibilities. Intentional Wellness MD markets a coordinated experience: digital intake, an independent clinician’s evaluation, compounded medication from a partner pharmacy and ongoing messaging. The central question is how clearly those handoffs are documented. This review follows the care pathway rather than treating the website, prescriber and dispensing pharmacy as one interchangeable medical service.

Public pages consulted October 19, 2026 describe semaglutide, tirzepatide and a GLP-1 Microdose program, with flat-rate pricing but no concrete dollar amounts in the reviewed text. They also contain differences concerning the operating company, cancellation deadlines and privacy representations. Those differences do not establish that care is unavailable or inadequate. They do mean a prospective patient needs written answers about the responsible organizations and applicable terms before allowing an enrollment payment to become a recurring care arrangement.

At a glance

Clinical responsibility: The platform says it does not practice medicine, prescribe or dispense; independent licensed practitioners make clinical decisions.
Sources: [11]
Advertised programs: Semaglutide, tirzepatide and GLP-1 Microdose are advertised. Semaglutide is explicitly described as injectable; the reviewed text does not establish the other two programs’ routes.
Sources: [10] [4] [5]
Pharmacy restriction: The terms require purchasers of a prescription-inclusive service to waive pharmacy choice for that purchase.
Sources: [8]
Recurring payment: Recurring monthly orders authorize an immediate charge and charges every 30 days thereafter; the reviewed pages provide no concrete price.
Sources: [8] [10]
Cancellation discrepancy: The footer specifies 30 days’ notice for memberships; the terms allow subscription cancellation through auto-refill controls at least 48 hours before monthly processing.
Sources: [11] [8]

Start by identifying the organizations behind the care

Intentional Wellness MD describes itself as a concierge telehealth platform connecting patients with independent clinical providers and state-licensed compounding pharmacies. Its disclaimer says the platform itself does not practice medicine, write prescriptions or dispense pharmaceuticals. It describes the professionals in its network as U.S. board-certified providers, but the consulted documentation does not name the treating clinicians, independent medical group or dispensing pharmacies. Those descriptions are provider claims, not independently verified credentials.

There is also an unresolved corporate distinction. The About page lists Intentional Wellness MD, LLC at 614 E. Sipapu Dr., Gilbert, Arizona 85297. Terms marked updated June 1, 2026 instead identify Ohana Health & Wealth, LLC as the website’s owner and operator. The reviewed material does not explain their relationship. Patients should establish which entity handles payments, which holds the clinical relationship and which organization receives a complaint about a prescription or delivery.

That separation matters when something needs correction. A platform support representative may coordinate an issue without being the professional responsible for prescribing or the pharmacist responsible for dispensing. Our guide to the clinician and platform relationship explains this distinction. For this service, a useful enrollment document would identify all three parties and provide direct contact routes, rather than relying on the shared Intentional Wellness MD branding to explain responsibility.

Responsibility checkpoints along the advertised care pathway
Stage	What the documentation says	What to confirm
Enrollment	A platform coordinates access to independent providers.	The contracting entity and treating medical group.
Clinical review	A consultation and prescription decision are required.	Consultation format, timing and clinician identity.
Dispensing	Partner compounding pharmacies prepare medication.	Pharmacy name, contact details and exact formulation.
Delivery	Temperature-controlled, unmarked packaging is advertised.	Dispatch timing and temperature-problem procedures.
Ongoing care	Direct messaging and structured check-ins are advertised.	Review frequency, response times and renewal requirements.

Sources: [6] [8] [11]

Intake is described, but the consultation format remains unclear

The advertised starting point is a comprehensive digital health history, followed by review of biomarkers, medical history and goals by a licensed provider. The homepage also mentions coordinating a diagnostic lab draw. Importantly, it explicitly identifies testing as required for TRT/HRT and advanced longevity protocols; that statement does not establish mandatory testing for every GLP-1 patient. The consulted pages do not specify whether GLP-1 testing is required, how often it occurs or who pays.

The terms make prescription access conditional: a patient must complete a consultation, the provider must determine that the product is appropriate and the provider must issue a prescription. Enrollment is therefore not a guaranteed prescription. The documentation does not establish whether the initial consultation is video, telephone or another format, nor does it give a clinical-review turnaround. Preparing a medication list and questions through our first-consultation guide can help make that encounter more productive.

The brand advertises telehealth across all 50 states and a nationwide provider network, but its terms qualify availability by state-specific rules that may change. During consultation, patients must be physically in the same state as their account’s shipping address. Access also requires being at least 18, or the age of majority where the patient lives if higher. Confirm availability for the actual consultation location, particularly before scheduling care while traveling.

Sources: [11] [8] [10]

The three GLP-1 offerings need different product questions

Semaglutide is marketed as a physician-directed program supervised by a licensed clinician, with home delivery and flat-rate pricing. Its page explicitly describes a weekly injection. Tirzepatide is promoted as a dual GLP-1/GIP program under physician direction, also with flat-rate pricing, but the consulted text does not explicitly identify its route. Ingredient names alone do not establish the exact formulation, concentration, presentation or quantity that an individual prescription would provide.

The semaglutide and tirzepatide pages advertise candidates aged 18 or older with a BMI of at least 27, or at least 25 with weight-related conditions. These are the provider’s advertised criteria, not an individualized eligibility determination. The semaglutide page lists exclusions including personal or family history of medullary thyroid carcinoma or MEN 2; pregnancy, breastfeeding or planned pregnancy; active pancreatitis; and untreated severe gastrointestinal disease. Tirzepatide marketing also addresses patients who have plateaued on a single-agonist GLP-1.

GLP-1 Microdose is presented differently: a lower-dose protocol aimed at body composition, metabolic health and longevity rather than aggressive weight loss. Its advertised audience includes people near goal weight and those who tolerated standard GLP-1 treatment poorly; it excludes people with significant weight to lose who would be better served by a standard protocol. These are marketing descriptions, not demonstrated outcomes. The consulted text does not identify Microdose’s active ingredient or route, and navigation mentioning Oral GLP-1s does not establish a documented oral offering.

Sources: [10] [4] [5]

The prescription moves into a restricted pharmacy channel

The semaglutide program’s advertised inclusions specify compounded medication prepared by partner pharmacies and shipped on a structured cadence. The platform describes its pharmacies as U.S.-based, state-licensed and FDA-regulated. Its disclaimer separately acknowledges that compounded medications are not FDA approved and that FDA has not independently verified their safety, efficacy and quality. Describing a pharmacy as regulated does not turn its preparation into an FDA-approved product, and dispensing and compounding are distinct responsibilities.

FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Compounded preparations do not undergo FDA premarket review for safety, effectiveness and quality; that fact alone does not establish clinical inequivalence. Intentional Wellness MD’s disclaimer similarly discusses custom formulations when commercial treatments do not meet individual needs. What remains undocumented here is the patient-specific reason, named pharmacy and exact preparation for any particular prescription.

The terms require patients purchasing prescription-inclusive services to waive the right to use a pharmacy of their choice for that purchase. Anyone expecting to transfer the prescription to a preferred local or insurance-network pharmacy should resolve that restriction before paying. Our pharmacy-handoff questions can help organize the conversation. The reviewed certificate PDFs did not yield readable clinical content, so they do not establish a laboratory identity, purity result or sterility finding for this review.

Sources: [10] [11] [8] [1]

Home delivery has packaging promises, not an arrival timetable

Intentional Wellness MD advertises discreet direct delivery in unmarked, temperature-controlled packaging. That describes the intended delivery arrangement, not a documented time from approval to arrival. The consulted pages do not specify clinical-review, preparation, dispatch or transit intervals, identify a carrier or explain how delivery exceptions are handled. A structured shipping cadence also does not establish the quantity of medication included in each payment or the number of usable treatment days supplied.

Temperature problems need a clear escalation route before the first shipment. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. The reviewed provider documentation does not detail its temperature-incident procedure, replacement policy or responsibility for resolving a delayed package. Our guide to warm injectable deliveries explains the FDA advice without substituting for a pharmacist’s assessment of a specific shipment.

Another consequential detail sits in the terms: prescription products will not be dispensed in child-resistant containers. Discreet packaging should not be mistaken for child-resistant medication packaging. Before shipment, patients should ask how the actual container is labeled, what storage instructions accompany it and whom to contact if the contents or instructions are unclear. FDA has received reports of compounded-medication measurement and administration errors, some associated with hospitalization; this review cannot supply patient dosing instructions.

Sources: [10] [8] [1]

Ongoing access is advertised more clearly than follow-up timing

The program says members are matched to a dedicated provider licensed in their state rather than passed between call centers. It also advertises direct concierge messaging with the provider and care team between scheduled check-ins, plus structured reviews calibrated to response. Those are meaningful service promises, but the consulted text does not define the review interval, clinician response standard or process when a dedicated clinician is unavailable. Messaging access is not the same thing as a documented urgent-care pathway.

The contact page lists support@intentionalwellnessmd.com and 1-480-433-8584, with clinical hours Monday through Friday, 9 a.m. to 5 p.m. MST in Arizona. Its contact form promises a team response within 24 hours. That is a contact-response claim, not a commitment to clinical approval, prescription preparation or delivery within that period. Prospective patients should distinguish administrative replies from a treating clinician’s response and ask how concerns outside posted hours are directed.

NIDDK describes medication selection as a discussion of benefits, side effects, current conditions, other medicines, family history and costs. Follow-up should address tolerance and response, not merely renewed payments. For Intentional Wellness MD, the practical missing details are when a clinical review becomes necessary, whether a refill can proceed before that review and how the prescriber communicates with the pharmacy when a plan changes. Those answers determine how coordinated the advertised ongoing care actually is.

Sources: [10] [7] [2]

Billing can continue on a different clock from care

The semaglutide page promises flat-rate pricing with no hidden fees, consultation charges or dose-change surcharges, but the consulted text supplies no dollar amount. The terms describe certain prescription subscriptions as a bundle covering the pharmacy’s medication fee, medical-group services and platform access. These statements can coexist if consultation costs are included rather than separately charged, but a written quote should explain the first payment, recurring amount, supply quantity and any testing or materials outside the bundle.

For recurring monthly orders, the terms authorize charging immediately and every 30 days until cancellation, with electronic notice five to seven days before a scheduled transaction. Thirty days is not a calendar month. The reviewed material does not establish minimum commitments, prepayment requirements, insurance acceptance or HSA/FSA arrangements. A homepage price-matching claim also lacks detailed qualifying conditions. None of these gaps permits calculating a reliable treatment total or assuming that every cost is covered by the flat-rate description.

Cancellation is especially unclear. The footer requires 30 days’ notice before the next membership billing cycle; subscription terms allow turning off auto-refill at least 48 hours before monthly processing. Do not assume these rules are interchangeable. The footer says treatment charges are not processed without medical approval, but consultations, memberships, visits and fulfilled prescriptions otherwise become nonrefundable once services begin or medication is processed. Cancellation therefore does not imply a refund; ask which deadline applies and what starts the nonrefundable service.

Sources: [10] [11] [8]

Privacy and adjacent services deserve separate explanations

The program FAQ says Intentional Wellness MD is HIPAA compliant, that medical information is shared only with the assigned provider and dispensing pharmacy, and that it never sells or shares data. The terms give a more qualified organizational description: Ohana Health & Wealth, LLC is not a HIPAA covered entity and may act as a business associate of a pharmacy or medical group in some circumstances. These statements should not be compressed into a blanket assurance about every interaction with the website.

The California privacy notice adds that some personal information may be made available to third parties for advertising measurement, delivery and relevance, and that these disclosures may constitute a sale or sharing under California law. That does not by itself establish that medical records are sold. It does mean the broad FAQ wording is insufficient to explain all data practices. Ask which information belongs to the clinical record, which is collected by the platform and which privacy choices apply to advertising.

The business also advertises provider-reviewed peptides compounded in a U.S. pharmacy and in-person stem-cell therapy for patients across the Phoenix valley. Those offerings are separate from the documented GLP-1 pathway. The consulted material does not establish the stem-cell procedure, product, eligibility or price. Their presence broadens the business’s wellness positioning, but it does not demonstrate GLP-1 treatment outcomes, validate longevity claims or fill the missing operational details about prescribers, pharmacy partners and follow-up.

Sources: [10] [8] [9] [11] [3]

Questions & answers

Will Intentional Wellness MD itself prescribe my medication?

Its disclaimer says no: independent licensed practitioners make evaluation and prescription decisions. The terms require a consultation, a determination that the product is appropriate and an issued prescription. Ask for the treating clinician’s name and medical group before assuming that platform enrollment establishes a clinical relationship or guarantees medication.

Sources: [11] [8]

Can I have the prescription sent to my usual pharmacy?

The terms require purchasers of a prescription-inclusive service to waive pharmacy choice for that purchase and use a pharmacy accessible through the platform. They say not to purchase if you do not wish to waive that right. The consulted pages do not name the dispensing partners, so request the pharmacy identity and contact information before paying.

Sources: [8]

What does the flat rate actually cost?

No concrete dollar amount appears in the reviewed text. The advertised program includes compounded medication and care features, while the terms describe bundled pharmacy, medical-group and platform fees. Obtain a written first-payment and renewal quote, supply quantity, and explanation of lab or materials charges. The price-matching promotion does not provide enough conditions to establish a discount.

Sources: [10] [8] [11]

How soon should I expect a first shipment?

The consulted pages do not establish a reliable approval-to-arrival interval. They advertise structured shipping and temperature-controlled delivery, while the contact form promises a team response within 24 hours. That response promise is not a shipping deadline. Ask separately about clinical review, pharmacy preparation, dispatch, transit and the procedure if a package is delayed.

Sources: [10] [7]

Does the Microdose program identify a specific medication?

Not in the consulted text. It describes a lower-dose GLP-1 protocol and its intended audience, but does not establish the active ingredient or route. Ask for the exact product, formulation, presentation and clinical rationale. Its body-composition and longevity positioning should not be treated as demonstrated effectiveness or as evidence about an individual’s likely result.

Sources: [5]

Which cancellation deadline should I follow?

The public documentation does not resolve that question: the footer gives memberships a 30-day notice requirement, while subscription terms specify disabling auto-refill at least 48 hours before monthly processing. Ask support to identify the rule governing your particular purchase and confirm cancellation in writing. Neither deadline creates a refund entitlement for services already begun or medication already processed.

Sources: [11] [8]

Our assessment

Intentional Wellness MD documents a recognizable care model: independent clinical review, partner-pharmacy compounded medication, home delivery, dedicated-provider positioning and messaging between check-ins. Its strengths are the explicit separation of platform and prescribing responsibilities and the description of several ongoing-care features. The practical weaknesses are unresolved handoffs: unnamed clinical and pharmacy partners, no concrete prices or delivery timetable, incomplete product details, and conflicting cancellation language. Corporate and privacy explanations also need clarification. Before enrolling, obtain one written account of the responsible entities, exact prescribed product, dispensing pharmacy, first and recurring charges, follow-up schedule and applicable cancellation deadline. Those answers would make the advertised convenience easier to evaluate without assuming either that marketing promises guarantee a seamless service or that documentation gaps prove poor care.

Visit Intentional Wellness MD’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

FOLLOW THE EVIDENCE

Research behind treatment claims

Use these studies to assess the type of outcome a treatment claim describes. They did not test this provider or establish results for its products.

SURMOUNT-5: What a Direct Weight-Loss Comparison Can—and Cannot—Tell You About Ongoing Care
Tirzepatide produced greater average weight and waist reductions than semaglutide over 72 weeks. Understanding the trial’s design matters just as much as understanding the difference.
After the Weight Loss: What SURMOUNT-4 Means for Continuity of Care
Randomized tirzepatide withdrawal separates maintaining a treatment effect from finishing a course. Reading its two baselines—and newer maintenance-dose research—shows what the evidence can and cannot tell patients changing care.

Explore the science library →

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Intentional Wellness MD Review: Following the Care From Intake to Home Delivery

At a glance

01Start by identifying the organizations behind the care

02Intake is described, but the consultation format remains unclear

03The three GLP-1 offerings need different product questions

04The prescription moves into a restricted pharmacy channel

05Home delivery has packaging promises, not an arrival timetable

06Ongoing access is advertised more clearly than follow-up timing

07Billing can continue on a different clock from care

08Privacy and adjacent services deserve separate explanations